Lv4
655 积分 2023-07-21 加入
Navigating established and emerging biomarkers for immune checkpoint inhibitor therapy
7小时前
待确认
Spatial immune scoring system predicts hepatocellular carcinoma recurrence
1天前
待确认
Targeting novel immune checkpoints in the B7-H family: advancing cancer immunotherapy from bench to bedside
1天前
待确认
Multi-scale signaling and tumor evolution in high-grade gliomas
2天前
已完结
2023 ESMO肾癌精粹解读
3天前
已完结
Letter to the Editor: The divergences in the efficacy of adjuvant transarterial chemoembolization for hepatocellular carcinoma: In-depth analysis and enlightenments
4天前
已完结
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
4天前
已完结
Immunotherapy in Glioblastoma: A Clinical Perspective
4天前
已完结
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
4天前
已完结
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
4天前
已完结
皖公网安备34019202002308
